Recall issued for PharmaTech liquids

Modesto Morganelli
Agosto 13, 2017

The recall comes after possible product contamination. The bacteria involved is Burkholderia cepacia, or B. cepacia. The recalled products were distributed nationwide at wholesale and retail facilities including hospitals and pharmacies. "Patients who are using liquid drug products and who have concerns should contact their healthcare professional". Instead, they contain the labels of distributors such as Leader Brand, Major Pharmaceuticals, and Rugby Laboratories.

The regulatory agency previously had warned against using PharmaTech's oral liquid docusate, after the Centers for Disease Control and Prevention detected a strain of the bacteria in the product following a 2016 multistate outbreak of infections.

Rugby Laboratories began recalling two PharmaTech oral liquid docusate products on August 3: Diocto Liquid and Diocto Syrup.

However, determining which products were manufactured by PharmaTech could prove hard "because these liquid products are not labeled with a PharmaTech label", the safety alert states. An FDA investigation traced the source of infection back to 10 lots of oral liquid docusate sodium manufactured by PharmaTech.

These products, which include various drugs and dietary supplements intended for use in infants and children, have been linked to a PharmaTech-manufactured product connected to severe adverse event reports of B. cepacia infections in patients.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE